BioNTech SE Balance Sheet Statement

BNTX $30.75 0.1 0.4%

14/02/20

Speculative, Large Cap, Sucker Stock

Market Cap £5.33bn

Enterprise Value £5.01bn

Revenue £113.0m

Quality

Value

Momentum

StockRank™

To unlock BioNTech SE's balance sheet statement please upgrade your membership.

	2016	2017	2018
Period End:	2016-12-31	2017-12-31	2018-12-31
Period Length:	0	0	0
Currency:	EUR	EUR	EUR

Cash & Equivalents
Short Term Investments
Cash and Short Term Investments
Accounts Receivable - Trade, Net
Total Receivables, Net
Total Inventory
Prepaid Expenses
Other Current Assets, Total
Total Current Assets

Property/Plant/Equipment, Total - Gross
Accumulated Depreciation, Total
Property/Plant/Equipment, Total - Net
Goodwill, Net
Intangibles, Net
Long Term Investments
Other Long Term Assets, Total
Total Assets

Accounts Payable
Notes Payable/Short Term Debt
Current Port. of LT Debt/Capital Leases
Other Current Liabilities, Total
Total Current Liabilities

Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Other Liabilities, Total
Total Liabilities

Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity

Total Liabilities & Shareholders’ Equity
Total Common Shares Outstanding

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.